TEM,PFE Stock Price and Quote

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change -2.18
Percentage change -3.37	%

Peers: ILMN EXAS GH TXG CRSP PACB NTLA EDIT CDNA TWST

| Held by: ARKK VTI VB ARKG VBK IBB JTEK ROBT IPO THNQ

Index	-	P/E	-	EPS (ttm)	-4.60	Insider Own	52.02%	Shs Outstand	167.99M	Perf Week	-4.02%
Market Cap	10.84B	Forward P/E	-	EPS next Y	-0.01	Insider Trans	-10.74%	Shs Float	83.06M	Perf Month	45.82%
Income	-721.31M	PEG	-	EPS next Q	-0.24	Inst Own	32.18%	Short Float	22.84%	Perf Quarter	-25.25%
Sales	803.32M	P/S	13.49	EPS this Y	53.72%	Inst Trans	0.39%	Short Ratio	1.51	Perf Half Y	-19.35%
Book/sh	1.89	P/B	33.21	EPS next Y	97.95%	ROA	-70.47%	Short Interest	18.97M	Perf Year	-
Cash/sh	1.26	P/C	49.53	EPS next 5Y	-	ROE	-	52W Range	22.89 - 91.45	Perf YTD	85.43%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-32.48%	ROI	-61.41%	52W High	-31.55%	Beta	-
Dividend TTM	-	Quick Ratio	1.56	Sales past 5Y	39.44%	Gross Margin	55.42%	52W Low	173.48%	ATR (14)	5.61
Dividend Ex-Date	Jul 18, 2006	Current Ratio	1.71	EPS Y/Y TTM	-160.27%	Oper. Margin	-87.17%	RSI (14)	58.80	Volatility	9.85% 8.61%
Employees	2400	Debt/Eq	2.63	Sales Y/Y TTM	42.93%	Profit Margin	-89.79%	Recom	2.07	Target Price	63.09
Option/Short	Yes / Yes	LT Debt/Eq	2.60	EPS Q/Q	27.16%	Payout	-	Rel Volume	0.88	Prev Close	64.78
Sales Surprise	3.07%	EPS Surprise	7.69%	Sales Q/Q	75.38%	Earnings	May 06 AMC	Avg Volume	12.55M	Price	62.60
SMA20	13.83%	SMA50	24.99%	SMA200	22.11%	Trades		Volume	11,185,366	Change	-3.37%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-21-25	Initiated	BTIG Research	Buy	$60
Feb-25-25	Downgrade	JP Morgan	Overweight → Neutral	$50 → $55
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-05-25	Resumed	TD Cowen	Buy	$58 → $74
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Dec-09-24	Initiated	Guggenheim	Buy	$74
Nov-11-24	Downgrade	Stifel	Buy → Hold	$45 → $65
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral	$45 → $60
Aug-12-24	Initiated	Piper Sandler	Neutral	$40
Jul-09-24	Initiated	William Blair	Outperform
Jul-09-24	Initiated	TD Cowen	Buy	$50
Jul-09-24	Initiated	Stifel	Buy	$45
Jul-09-24	Initiated	Needham	Buy	$47
Jul-09-24	Initiated	Morgan Stanley	Overweight	$44
Jul-09-24	Initiated	Loop Capital	Buy	$48
Jul-09-24	Initiated	Longbow	Buy	$48
Jul-09-24	Initiated	JP Morgan	Overweight	$42
Jul-09-24	Initiated	BofA Securities	Buy	$41

Show Previous Ratings

May-15-25 03:00PM	After 92% YTD Surge, Is Tempus AI a Buy on Trump's Executive Order? (Zacks)
04:48AM	Boehringer partners Tempus AI to enhance cancer therapy pipeline (Pharmaceutical Technology)
May-14-25 08:30AM	Tempus Enters Multi-Year Strategic Collaboration With Boehringer Ingelheim to Advance Its Cancer Pipeline (Business Wire) -5.99%
May-13-25 07:40PM	Why Tempus AI Inc. (TEM) Skyrocketed On Tuesday (Insider Monkey) +9.92%
04:05PM	Tempus Announces Six Posters Accepted for Presentation at ISPOR 2025 (Business Wire)
11:34AM	Loading…
11:34AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (and Sold) (Motley Fool)
11:11AM	Is Tempus AI, Inc. (TEM) the Best Performing Healthcare Stock to Buy Now? (Insider Monkey)
06:45AM	Tradr Launches First Leveraged ETF on Tempus AI (PR Newswire)
May-10-25 09:50AM	Jim Cramer Says Stay Away from This Nancy Pelosi Stock (Insider Monkey)
07:00AM	MarketBeat Week in Review - 05/05 - 05/09 (MarketBeat)
May-09-25 11:30AM	These AI Stocks Posted Robust Results: Time to Buy? (Zacks) -5.90%
May-08-25 07:45AM	Tempus AI Stock: Time to Double Down or Cut and Run? (MarketBeat) +10.99%
01:48AM	Why Tempus AI, Inc. (TEM) Skyrocketed On Wednesday (Insider Monkey)
May-07-25 12:34PM	Q1 2025 Tempus AI Inc Earnings Call (Thomson Reuters StreetEvents) +12.59%
07:49AM	Tempus AI, Inc. (TEM): Among Most Popular Stocks on Robinhood in 2025 (Insider Monkey)
03:22AM	Loading…
03:22AM	Tempus AI Inc (TEM) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
May-06-25 04:01PM	Tempus Reports First Quarter 2025 Results (Business Wire)
May-05-25 05:07PM	Jim Cramer Warns on Tempus AI (TEM): "Diagnostics With no Dough? I'm Out" (Insider Monkey) -5.24%
12:35PM	AI Healthcare Boom Gains Speed as Regulators and Innovators Align (PR Newswire)
08:30AM	Tempus Announces Notetaker, its AI-Powered Clinical Assistant for Psychiatry (Business Wire)
May-02-25 08:58AM	Think It's Too Late to Buy Tempus AI? Here's the Biggest Reason Why There's Still Time. (Motley Fool) +10.05%
05:32AM	Tempus selects TIME Network for Phase I clinical trials (Clinical Trials Arena)
May-01-25 11:04AM	New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty (PR Newswire)
08:30AM	Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment (Business Wire)
Apr-30-25 05:32AM	Is This the Best Nancy Pelosi Stock to Buy After a 40% Pullback? (Motley Fool)
Apr-29-25 08:45AM	Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth (GlobeNewswire)
08:30AM	Tempus Publishes Study Validating the Benefits of xF+, its Comprehensive Liquid Biopsy Assay for Therapy Selection (Business Wire)
Apr-28-25 03:00PM	Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings? (Zacks)
08:30AM	Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform (Business Wire)
Apr-26-25 02:04PM	Why Tempus AI Inc. (TEM) Soared Last Week (Insider Monkey)
08:30AM	Loading…
Apr-25-25 08:30AM	Tempus Announces 18 Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025 (Business Wire)
07:29AM	Tempus AI, AstraZeneca, and Pathos AI join forces on cancer care (Pharmaceutical Business Review)
04:49AM	The Zacks Analyst Blog Highlights Tempus AI, AstraZeneca, iRhythm Technologies and SOPHiA GENETICS (Zacks)
Apr-24-25 03:00PM	Tempus AI Stock Sees 21% Gain in 3 Days: Is it a Buy After AZN Deal? (Zacks) +7.97%
08:30AM	Tempus to Report First Quarter 2025 Financial Results on May 6 (Business Wire)
07:33AM	AstraZeneca enters $200m AI cancer pact with Tempus and Pathos (Pharmaceutical Technology)
Apr-23-25 07:59PM	Tempus AI, Inc. (TEM): A Bull Case Theory (Insider Monkey) +14.62%
06:16PM	Why Tempus AI Inc. (TEM) Went Up On Wednesday (Insider Monkey)
02:01PM	Tempus AI Is Skyrocketing Today -- Is the Stock a Buy Right Now? (Motley Fool)
01:26PM	Is Tempus AI, Inc. (TEM) the Best Nancy Pelosi Stock To Invest In Now? (Insider Monkey)
10:48AM	Why Tempus AI Stock Is Skyrocketing Today (Motley Fool)
08:00AM	Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology (Business Wire)
Apr-22-25 09:47AM	Tempus AI (TEM) Initiated at 'Buy' with $60 Price Target by BTIG (Insider Monkey) +5.49%
06:34AM	Tempus AI: Cooldown Arrived (Rating Upgrade) (Seeking Alpha)
Apr-21-25 03:04PM	Tempus AI Gets Bullish Boost from BTIG on Data Strength, Expansion Moves (GuruFocus.com)
Apr-20-25 10:20AM	Tempus: The AI Engine Powering Healthcare (Seeking Alpha)
Apr-18-25 08:30AM	Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S. (Business Wire)
05:00AM	Illumina, Tempus AI partner to drive genomic testing beyond cancer (MedTech Dive)
Apr-16-25 08:45AM	Global AI Diagnostics Market to Reach $8.54 Billion By 2033 as Industry Sees Increasing R&D and Strategic Collaborations (GlobeNewswire)
Apr-15-25 09:15AM	Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation (PR Newswire)
Apr-14-25 10:49AM	3 Hot New IPOs Defying the 2025 Market Slump (MarketBeat)
Apr-11-25 03:00PM	Tempus AI vs. Doximity: Which AI in Healthcare Stock is a Better Buy? (Zacks)
Apr-10-25 03:00PM	Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025 (Zacks) -7.99%
Apr-09-25 06:15AM	Why Tempus AI Inc. (TEM) Went Down On Tuesday? (Insider Monkey) +17.62%
Apr-04-25 07:15PM	Tempus AI, Inc. (TEM): Among Stocks That Will Profit From AI (Insider Monkey) -7.78%
Apr-01-25 03:00PM	Tempus AI Surges 43% YTD: Is it the Right Time to Invest in the Stock? (Zacks)
Mar-30-25 07:10AM	abrdn World Healthcare Fund Q4 2024 Commentary (Seeking Alpha)
03:25AM	abrdn Healthcare Opportunities Fund Q4 2024 Commentary (Seeking Alpha)
Mar-29-25 08:30AM	Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting (Business Wire)
07:15AM	4 Healthcare Stocks With Massive Gains-and More to Come (MarketBeat)
Mar-27-25 03:55AM	Why Tempus AI Inc. (TEM) Crashed On Wednesday? (InsiderMonkey)
Mar-26-25 10:58AM	Is Tempus AI Inc. (NASDAQ:TEM) the Best AI Stock to Invest in According to Reddit? (InsiderMonkey) -9.08%
08:30AM	Tempus to Present at the 24th Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-25-25 08:45AM	AI Influence on Medical Diagnostics Generating Billion Dollar Revenues While Growing Adoption Reduces Healthcare Costs (GlobeNewswire)
08:30AM	Tempus AI's Valuation Bakes In Strong Growth - A Hold For Now (SeekingAlpha)
Mar-24-25 11:49PM	Tempus AI Inc. (TEM)Among Cathie Wood's Top AI Stock Picks in 2025 (InsiderMonkey) +14.90%
Mar-22-25 03:15AM	Why Tempus AI (TEM) Went Up On Friday? (InsiderMonkey)
Mar-19-25 02:13PM	Tap Billion-Dollar AI Opportunity in Oncology: Stocks in the Spotlight (Zacks) +5.01%
Mar-17-25 09:08AM	Tempus AI (TEM) Expands Precision Medicine Capabilities with Deep 6 AI Acquisition (Insider Monkey) +5.72%
Mar-16-25 10:17PM	Tempus AI, Inc. (TEM): Among Top Insider Sales Last Month (Insider Monkey)
Mar-14-25 10:10AM	Is Tempus AI, Inc. (TEM) the Best Performing Growth Stock in 2025? (Insider Monkey) +11.87%
Mar-11-25 05:15PM	Tempus Announces Acquisition of Deep 6 AI (Business Wire)
10:09AM	Why Tempus AI (TEM) Shares Are Soaring: The Cathie Wood Effect (Insider Monkey)
Mar-07-25 10:00PM	Why Does Nancy Pelosi Like Tempus AI (TEM) Stock So Much? (Benzinga) -8.00%
09:10PM	Tempus AI, Inc. (TEM): Among The Stocks With At Least $10 Million In Insider Sales Recently (Insider Monkey)
Mar-05-25 11:20AM	JPMorgan Downgrades Tempus AI, Inc. (TEM) to Neutral Despite Positive 2025 Guidance (Insider Monkey)
Mar-03-25 03:33PM	Analyst says AI stock picked by Cathie Wood will surge (TheStreet) -9.34%
Mar-02-25 06:20AM	Street Calls of the Week (Investing.com)
Feb-27-25 06:26PM	Tempus AI, Inc. (TEM) Reaffirmed as Buy with Strong Growth Outlook (Insider Monkey) -11.18%
12:04PM	SCOPE 2025: investors share optimism and obstacles for AI in clinical operations (Pharmaceutical Technology)
Feb-26-25 05:47PM	Cathie Wood buys $27 million of tumbling AI stock (TheStreet) +5.35%
12:27PM	Why Tempus AI, Inc. (TEM) Went Down on Tuesday (Insider Monkey)
11:10AM	Ark Invest Buys the Dip as Cathie Wood Snaps Up Tempus AI Shares (GuruFocus.com)
10:00AM	Tempus AI Stock Has Soared 108% Already in 2025; Is It a Buy Now? (Motley Fool)
Feb-25-25 04:22PM	Tempus AI Reverses 192% Run. Why At Least One Analyst Remains A Believer. (Investor's Business Daily) -15.05%
03:38PM	Tempus AI, Inc. (TEM) Reports Strong Q4 Growth, Fueled by AI-Driven Diagnostics (Insider Monkey)
03:32PM	Stock Market Today: Dow Jones Improves; Tesla Skids Again While Techs Keep Tumbling (Live Coverage) (Investor's Business Daily)
11:07AM	Stock Market Today: Dow Jones, S&P 500 Fall; Hims & Hers Tanks, Bitcoin Falls (Live Coverage) (Investor's Business Daily)
11:05AM	Tempus AI Costs, Outlook Send Stock Sharply Lower (Investopedia)
10:31AM	Q4 2024 Tempus AI Inc Earnings Call (Thomson Reuters StreetEvents)
10:05AM	JP Morgan cuts Tempus AI rating to neutral after stocks sharp rally (Investing.com)
09:29AM	Tempus AI, Inc. (TEM) and Menarini Group Leverage AI to Advance Breast Cancer Care (Insider Monkey)
02:03AM	Tempus AI Inc (TEM) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Moves (GuruFocus.com)
Feb-24-25 05:36PM	Tempus Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
05:23PM	Tempus AI Stock Drops After Company Posts Q4 Results (Investor's Business Daily)
04:25PM	Tempus: Q4 Earnings Snapshot (Associated Press Finance)
Feb-22-25 12:52AM	Tempus AI, Inc. (TEM) Secures $300 Million to Fuel Ambry Genetics Acquisition (Insider Monkey)
Feb-21-25 07:32AM	Why Tempus AI, Inc. (TEM) Crashed on Thursday (Insider Monkey) -11.25%
Feb-20-25 10:43AM	Why Tempus AI, Inc (TEM) is the Best Performing Healthcare Stock So Far in 2025 (Insider Monkey) -10.49%
Feb-19-25 03:58PM	Why Tempus AI (TEM) Crashed on Tuesday? (Insider Monkey)

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Leonsis Theodore	Director	May 09 '25	Sale	66.26	770	51,020	43,550	May 13 04:15 PM
REVOLUTION GROWTH III, LP	Shareholder	May 09 '25	Proposed Sale	65.22	770	50,219		May 09 04:18 PM
Fukushima Ryan	Chief Operating Officer	May 06 '25	Sale	52.36	20,000	1,047,239	884,460	May 08 04:30 PM
Epstein David R	Director	May 01 '25	Sale	53.50	370	19,795	25,914	May 05 04:15 PM
Gottlieb Scott	Director	Apr 01 '25	Sale	47.21	27,837	1,314,154	32,839	Apr 03 05:30 PM
Doudna Jennifer A	Director	Apr 01 '25	Sale	48.12	625	30,075	25,740	Apr 03 04:15 PM
Fukushima Ryan	Chief Operating Officer	Apr 01 '25	Sale	47.20	20,000	944,085	904,460	Apr 03 04:15 PM
Frederick Wayne A.I.	Director	Mar 31 '25	Sale	45.54	3,000	136,620	26,514	Apr 02 06:13 PM
RYAN FUKUSHIMA	Officer	Apr 01 '25	Proposed Sale	48.24	60,000	2,894,400		Apr 01 04:22 PM
Polovin Andrew	EVP and General Counsel	Mar 21 '25	Sale	50.00	3,076	153,800	151,095	Mar 25 04:15 PM
ANDREW POLOVIN	Officer	Mar 21 '25	Proposed Sale	48.04	3,076	147,771		Mar 21 04:21 PM
Rogers James William	Chief Financial Officer	Mar 18 '25	Sale	45.97	23,030	1,058,699	164,750	Mar 19 06:30 PM
Polovin Andrew	EVP and General Counsel	Mar 18 '25	Sale	45.98	13,135	603,970	154,171	Mar 19 06:30 PM
Epstein David R	Director	Mar 17 '25	Sale	46.83	990	46,362	26,284	Mar 19 06:30 PM
West Nadja	Director	Mar 17 '25	Sale	48.86	7,634	372,962	30,071	Mar 19 06:30 PM
Gottlieb Scott	Director	Mar 17 '25	Sale	48.85	27,838	1,359,989	60,676	Mar 19 06:30 PM
Frederick Wayne A.I.	Director	Mar 17 '25	Sale	48.85	9,000	439,659	29,514	Mar 19 06:30 PM
Doudna Jennifer A	Director	Mar 17 '25	Sale	48.80	9,308	454,210	26,365	Mar 19 06:30 PM
ANDREW POLOVIN	Officer	Mar 18 '25	Proposed Sale	49.87	13,135	655,042		Mar 18 04:41 PM
JAMES ROGERS	Officer	Mar 18 '25	Proposed Sale	49.87	23,030	1,148,506		Mar 18 04:27 PM
WAYNE FREDERICK	Director	Mar 17 '25	Proposed Sale	47.17	12,000	566,040		Mar 17 04:47 PM
DAVID R. EPSTEIN	Director	Mar 17 '25	Proposed Sale	47.17	1,610	75,944		Mar 17 04:25 PM
SCOTT GOTTLIEB	Director	Mar 17 '25	Proposed Sale	47.17	55,675	2,626,190		Mar 17 04:23 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 05 '25	Sale	50.93	562,345	28,641,725	9,457,283	Mar 07 04:56 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 06 '25	Sale	49.83	250,000	12,457,454	9,407,283	Mar 07 04:56 PM
Fukushima Ryan	Chief Operating Officer	Mar 04 '25	Sale	51.15	20,000	1,022,974	924,460	Mar 06 05:05 PM
West Nadja	Director	Mar 04 '25	Sale	51.11	809	41,347	37,705	Mar 06 05:05 PM
Eric P. Lefkofsky	Officer	Mar 05 '25	Proposed Sale	52.73	662,345	34,925,452		Mar 05 05:44 PM
Doudna Jennifer A	Director	Mar 03 '25	Sale	57.52	338	19,442	35,673	Mar 05 04:15 PM
Epstein David R	Director	Mar 03 '25	Sale	57.52	250	14,380	27,274	Mar 05 04:15 PM
NADJA WEST	Director	Mar 04 '25	Proposed Sale	50.93	8,443	430,002		Mar 04 05:08 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 27 '25	Sale	58.75	3,240,234	190,363,748	0	Feb 27 07:39 PM
Lightbank Investments 1B, LLC	Affiliate	Feb 27 '25	Proposed Sale	59.10	115,751	6,840,884		Feb 27 04:27 PM
Innovation Group Investors, L.	Affiliate	Feb 27 '25	Proposed Sale	59.10	1,580,928	93,432,845		Feb 27 04:26 PM
Lightbank Global, LLC	Affiliate	Feb 27 '25	Proposed Sale	59.10	1,397,589	82,597,510		Feb 27 04:25 PM
Innovation Group Investors, L.	Affiliate	Feb 27 '25	Proposed Sale	59.10	145,966	8,626,591		Feb 27 04:24 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 19 '25	Sale	80.87	84,640	6,844,680	4,964,820	Feb 20 07:55 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 20 '25	Sale	74.09	69,231	5,129,325	4,895,589	Feb 20 07:55 PM
Fukushima Ryan	Chief Operating Officer	Feb 19 '25	Sale	81.87	2,868	234,814	944,460	Feb 20 07:55 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 20 '25	Sale	80.00	1,682	134,560	44,500	Feb 20 07:55 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 19 '25	Sale	81.87	818	66,973	46,182	Feb 20 07:55 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 18 '25	Sale	82.36	61,582	5,072,077	153,080	Feb 20 07:55 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 19 '25	Sale	81.87	903	73,932	152,177	Feb 20 07:55 PM
Polovin Andrew	EVP and General Counsel	Feb 18 '25	Sale	82.32	64,381	5,299,820	172,857	Feb 20 07:55 PM
Polovin Andrew	EVP and General Counsel	Feb 19 '25	Sale	81.87	5,551	454,470	167,306	Feb 20 07:55 PM
Rogers James William	Chief Financial Officer	Feb 18 '25	Sale	82.33	31,780	2,616,308	189,320	Feb 20 07:55 PM
Rogers James William	Chief Financial Officer	Feb 19 '25	Sale	81.87	1,540	126,086	187,780	Feb 20 07:55 PM
RYAN BARTOLUCCI	Officer	Feb 20 '25	Proposed Sale	85.71	1,682	144,164		Feb 20 04:22 PM
JAMES ROGERS	Officer	Feb 18 '25	Proposed Sale	89.44	31,780	2,842,403		Feb 18 04:29 PM
ANDREW POLOVIN	Officer	Feb 18 '25	Proposed Sale	89.44	64,381	5,758,237		Feb 18 04:29 PM
ERIK PHELPS	Officer	Feb 18 '25	Proposed Sale	89.44	61,582	5,507,894		Feb 18 04:28 PM
Doudna Jennifer A	Director	Feb 14 '25	Sale	90.00	1,320	118,800	36,011	Feb 14 07:53 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 14 '25	Sale	85.78	80,003	6,862,467	5,049,460	Feb 14 04:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 13 '25	Sale	78.51	78,594	6,170,792	5,129,463	Feb 14 04:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 12 '25	Sale	70.02	84,948	5,948,059	5,208,057	Feb 14 04:33 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 13 '25	Sale	80.00	6,059	484,720	47,000	Feb 14 04:32 PM
JENNIFER A DOUDNA	Director	Feb 14 '25	Proposed Sale	83.75	11,253	942,439		Feb 14 04:23 PM
RYAN BARTOLUCCI	Officer	Feb 13 '25	Proposed Sale	73.88	6,059	447,639		Feb 13 04:31 PM
LEFKOFSKY ERIC P	Officer	Feb 12 '25	Proposed Sale	71.21	535,000	38,097,350		Feb 12 08:21 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Feb 05 '25	Sale	67.57	5,934	400,960	214,662	Feb 07 05:38 PM
Polovin Andrew	EVP and General Counsel	Feb 05 '25	Sale	67.57	7,717	521,438	237,238	Feb 07 05:36 PM
Rogers James William	Chief Financial Officer	Feb 05 '25	Sale	67.57	8,712	588,670	221,100	Feb 07 05:35 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 06 '25	Sale	71.00	2,320	164,720	53,059	Feb 07 05:34 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 05 '25	Sale	67.57	1,858	125,545	55,379	Feb 07 05:34 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 06 '25	Sale	67.89	85,109	5,778,114	5,373,393	Feb 07 05:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 07 '25	Sale	67.53	80,388	5,428,398	5,293,005	Feb 07 05:33 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 05 '25	Sale	67.53	74,485	5,030,067	5,458,502	Feb 07 05:33 PM
Fukushima Ryan	Chief Operating Officer	Feb 04 '25	Sale	62.50	20,000	1,250,033	962,442	Feb 06 06:02 PM
Fukushima Ryan	Chief Operating Officer	Feb 05 '25	Sale	67.57	15,114	1,021,253	947,328	Feb 06 06:02 PM
RYAN BARTOLUCCI	Officer	Feb 06 '25	Proposed Sale	69.18	2,320	160,498		Feb 06 04:23 PM
Epstein David R	Director	Feb 03 '25	Sale	53.31	370	19,725	27,524	Feb 05 06:06 PM
Bartolucci Ryan M	Chief Accounting Officer	Jan 31 '25	Sale	60.00	13,770	826,200	57,237	Jan 31 09:26 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 31 '25	Sale	58.21	82,056	4,776,799	5,532,987	Jan 31 09:23 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 29 '25	Sale	53.86	79,118	4,261,125	5,692,669	Jan 31 09:23 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 30 '25	Sale	54.63	77,626	4,240,708	5,615,043	Jan 31 09:23 PM
RYAN BARTOLUCCI	Officer	Jan 31 '25	Proposed Sale	57.19	13,770	787,506		Jan 31 04:34 PM
LEFKOFSKY ERIC P	Officer	Jan 29 '25	Proposed Sale	51.02	520,000	26,530,400		Jan 29 08:44 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 23 '25	Sale	52.26	645,068	33,709,713	5,857,575	Jan 24 06:53 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 22 '25	Sale	49.84	476,209	23,733,244	6,502,643	Jan 24 06:53 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 24 '25	Sale	53.39	85,788	4,580,274	5,771,787	Jan 24 06:53 PM
LEFKOFSKY ERIC P	Officer	Jan 24 '25	Proposed Sale	54.84	85,788	4,704,614		Jan 24 06:50 PM
LEFKOFSKY ERIC P	Officer	Jan 23 '25	Proposed Sale	50.45	645,068	32,543,681		Jan 23 09:14 PM
LEFKOFSKY ERIC P	Officer	Jan 22 '25	Proposed Sale	47.64	476,209	22,686,597		Jan 22 09:29 PM
KEYWELL BRADLEY A	10% Owner	Jan 16 '25	Sale	34.84	510,364	17,781,775	15,483,365	Jan 17 06:15 PM
KEYWELL BRADLEY A	10% Owner	Jan 17 '25	Sale	35.10	265,000	9,302,159	15,218,365	Jan 17 06:15 PM
KEYWELL BRADLEY A	10% Owner	Jan 15 '25	Sale	35.45	170,720	6,052,768	15,993,729	Jan 17 06:15 PM
Fukushima Ryan	Chief Operating Officer	Jan 07 '25	Sale	39.61	20,000	792,192	982,442	Jan 08 04:23 PM
Fukushima Ryan	Chief Operating Officer	Jan 02 '25	Sale	34.66	1,265	43,845	1,002,442	Jan 03 04:52 PM
Fukushima Ryan	Officer	Jan 02 '25	Proposed Sale	33.76	1,265	42,706		Jan 02 07:19 PM
LEFKOFSKY ERIC P	CEO and Chairman	Dec 18 '24	Sale	37.54	187,655	7,045,334	9,557,283	Dec 20 09:00 PM
Rogers James William	Chief Financial Officer	Dec 16 '24	Sale	40.23	1,468	59,058	229,812	Dec 18 08:15 PM
Polovin Andrew	EVP and General Counsel	Dec 16 '24	Sale	40.23	1,130	45,460	244,955	Dec 18 08:15 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Dec 16 '24	Sale	40.23	2,396	96,391	220,596	Dec 18 08:15 PM
Fukushima Ryan	Chief Operating Officer	Dec 16 '24	Sale	40.23	3,500	140,805	1,003,707	Dec 18 08:15 PM
Bartolucci Ryan M	Chief Accounting Officer	Dec 16 '24	Sale	40.23	339	13,638	71,007	Dec 18 08:15 PM
LEFKOFSKY ERIC P	Officer	Dec 18 '24	Proposed Sale	38.95	400,000	15,580,000		Dec 18 05:21 PM
Polovin Andrew	EVP and General Counsel	Dec 11 '24	Sale	42.39	51,504	2,183,187	246,085	Dec 13 06:20 PM
Epstein David R	Director	Dec 11 '24	Sale	41.81	620	25,922	27,894	Dec 13 06:20 PM
Doudna Jennifer A	Director	Dec 11 '24	Sale	41.81	1,183	49,461	37,331	Dec 13 06:20 PM
Fukushima Ryan	Chief Operating Officer	Dec 11 '24	Sale	42.51	120,000	5,101,728	1,007,207	Dec 13 06:20 PM

Dollar change +0.58
Percentage change 2.63	%

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO SPY IVV VTV XLV VYM VHT COWZ DVY

Index	S&P 500	P/E	16.38	EPS (ttm)	1.38	Insider Own	0.06%	Shs Outstand	5.68B	Perf Week	-1.61%
Market Cap	128.49B	Forward P/E	7.33	EPS next Y	3.08	Insider Trans	0.50%	Shs Float	5.68B	Perf Month	0.71%
Income	7.87B	PEG	-	EPS next Q	0.56	Inst Own	66.61%	Short Float	2.03%	Perf Quarter	-11.86%
Sales	62.46B	P/S	2.06	EPS this Y	-3.18%	Inst Trans	-0.23%	Short Ratio	2.13	Perf Half Y	-13.87%
Book/sh	15.89	P/B	1.42	EPS next Y	2.40%	ROA	3.67%	Short Interest	115.16M	Perf Year	-20.53%
Cash/sh	3.05	P/C	7.42	EPS next 5Y	-0.28%	ROE	8.62%	52W Range	20.92 - 31.54	Perf YTD	-14.81%
Dividend Est.	1.71 (7.55%)	P/FCF	11.45	EPS past 5Y	-13.25%	ROI	5.32%	52W High	-28.34%	Beta	0.51
Dividend TTM	1.70 (7.52%)	Quick Ratio	0.96	Sales past 5Y	17.19%	Gross Margin	66.93%	52W Low	8.06%	ATR (14)	0.71
Dividend Ex-Date	May 09, 2025	Current Ratio	1.26	EPS Y/Y TTM	2770.58%	Oper. Margin	27.53%	RSI (14)	45.12	Volatility	2.92% 2.74%
Employees	81000	Debt/Eq	0.69	Sales Y/Y TTM	13.38%	Profit Margin	12.59%	Recom	2.38	Target Price	28.26
Option/Short	Yes / Yes	LT Debt/Eq	0.64	EPS Q/Q	-5.13%	Payout	119.94%	Rel Volume	0.95	Prev Close	22.02
Sales Surprise	-1.47%	EPS Surprise	38.22%	Sales Q/Q	-7.82%	Earnings	Apr 29 BMO	Avg Volume	54.16M	Price	22.60
SMA20	-1.64%	SMA50	-5.77%	SMA200	-15.10%	Trades		Volume	51,800,092	Change	2.63%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60

Show Previous Ratings

May-15-25 04:43PM	House Pushes Pfizer on Vaccine Timing (GuruFocus.com)
11:20AM	New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel (The Wall Street Journal)
08:36AM	5 Low Price-to-Book Value Stocks to Buy in May (Zacks)
08:27AM	FDA delays approval decision for Biohaven rare disease drug (BioPharma Dive)
May-14-25 06:05PM	3 Magnificent S&P 500 Dividend Stocks Down 62%, 63%, and 64% to Buy and Hold Forever (Motley Fool)
02:34PM	Loading…
02:34PM	Analyst Report: Pfizer Inc. (Morningstar Research)
10:15AM	Jim Cramer on Pfizer (PFE) - "Caught in a Vortex, but I'm Sticking with Seagen and Dr. Bourla" (Insider Monkey)
07:46AM	Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer (Zacks)
04:32AM	Court rules in favor of The New York Times over texts between the EU chief and a pharma boss (Associated Press Finance)
03:40AM	EU court annuls rejection of bid for EU's von der Leyen vaccine messages with Pfizer (Reuters)
03:40AM	Court rejects European Commission's refusal to share COVID messages with NY Times (Reuters)
03:40AM	Court annuls European Commission's refusal to disclose COVID texts (Reuters)
May-13-25 05:07PM	Why Pfizer Inc. (PFE) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom (Insider Monkey)
11:40AM	PFE vs. LLY: Which Stock Is the Better Value Option? (Zacks)
11:18AM	Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trumps Executive Order. (Barrons.com)
10:37AM	Loading…
10:37AM	4 Value Picks to Ride the Market Rebound After US-China Trade Thaw (Zacks)
09:40AM	Should Value Investors Buy Pfizer (PFE) Stock? (Zacks)
09:22AM	The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen (Zacks)
09:00AM	US-China Talks Spark Optimism; Betting Markets See Recession Odds Drop (Zacks)
07:36AM	Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared (Zacks)
May-12-25 08:59PM	Lightning Round: Devon Energy has been a nightmare, says Jim Cramer (CNBC TV)
07:20PM	Trump's drug price order is part request, part threat: Analyst (Yahoo Finance Video)
04:17PM	These Stocks Moved the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More (Barrons.com)
03:50PM	How Trump could go about executing order to slash drug prices (Yahoo Finance Video)
02:58PM	Trump Executive Order Could Reshape How Americans Pay for Drugs. Why It Isnt Bad for Pharma Stocks. (Barrons.com)
02:35PM	Global Pharma Stocks Rebound as Investors See Hurdles in Trump Drug Plan (Investopedia)
02:30PM	These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More (Barrons.com)
12:34PM	Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order (Yahoo Finance)
10:44AM	Trump expected to sign order to slash US drug prices (Yahoo Finance Video)
09:37AM	Pharma Stocks Hit by Trump's Vow to Cut US Prescription Drug Costs (Zacks)
09:25AM	Loading…
09:25AM	Zacks.com featured highlights PCB, G-III Apparel, Gibraltar, Pfizer and Pampa Energia (Zacks)
09:09AM	US-China trade truce, April CPI, drug prices: 3 Things (Yahoo Finance Video)
08:50AM	Zacks Market Edge Highlights: WHR, PFE, CVX, CC and DOW (Zacks)
07:55AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:49AM	Pfizer, Eli Lilly, Merck and Other Pharma Stocks Fall as Trump Targets Lower Drug Prices (Barrons.com)
07:38AM	Trumps Vow to Cut US Drug Prices Drags Pharma Stocks Lower (Bloomberg)
07:33AM	Trumps Plan to Cut Drug Prices Hits Pfizer, Other Pharma Stocks (The Wall Street Journal)
04:51AM	Wondering if Pfizer's 7.6% Dividend Yield Is Sustainable? Here's What You Need to Know. (Motley Fool)
04:28AM	Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices (Bloomberg)
May-10-25 05:39AM	3 Magnificent S&P 500 Dividend Stocks Down 30% to Buy and Hold Forever (Motley Fool)
04:17AM	Is Pfizer Inc. (PFE) the Best High-Yield Dividend Stock for 2025 and Beyond? (Insider Monkey)
May-09-25 12:44PM	Are Your Mega-High Stock Dividends Safe? (Zacks)
09:55AM	Pfizer (PFE) Just Overtook the 20-Day Moving Average (Zacks)
08:23AM	Was Jim Cramer Right About Pfizer (PFE)? (Insider Monkey)
08:12AM	5 Low Price-to-Sales Stocks That Deserve a Place in Your Portfolio (Zacks)
May-08-25 10:01PM	If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
11:50AM	A Look at Pharma ETFs After Strong Q1 Earnings (Zacks)
09:55AM	Can Pfizer (PFE) Climb 25.14% to Reach the Level Wall Street Analysts Expect? (Zacks)
05:45AM	Want $3,100 in Annual Dividends? Invest $18,000 in Each of These 3 Stocks (Motley Fool)
04:00AM	Alnylam keeps pushing the rare disease paradigm as RNAi promises even wider indications (Pharma Voice)
12:30AM	Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 Guidance (Seeking Alpha)
May-07-25 04:51PM	Trump planning on Executive Order to further cut Medicare drug prices - report (Seeking Alpha)
02:54PM	FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight (Benzinga)
01:50PM	Jim Cramer on Pfizer (PFE): "Trying Big Targets, but New Wins Still Elusive" (Insider Monkey)
11:35AM	2024 Total Dividend Income And Portfolio Update (Seeking Alpha)
10:32AM	Pfizer, J&J, Genentech drugs subject of FDA advisory panel meeting this month (Seeking Alpha)
05:30AM	Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better. (The Wall Street Journal)
May-06-25 06:15PM	Why BioNTech Stock Got Trounced on Tuesday (Motley Fool)
01:25PM	Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers. (Barrons.com)
09:54AM	Moderna Sharpens Pipeline Focus as COVID-19 Vaccine Demand Ebbs in Q1 (Zacks)
04:33AM	Why Viking Therapeutics Stock Surged Nearly 20% Higher in April (Motley Fool)
May-05-25 02:49PM	Optimism Is Back for Biotech Stocks. This Time, It Could Last. (Barrons.com)
09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:22AM	Top Wide-Moat Stocks to Invest in for Long-Term Growth (Zacks)
08:10AM	Pfizer Stock Up 5% Following Q1 Results: Time to Buy, Sell or Hold? (Zacks)
08:00AM	Biohaven Is Now A Compelling Contrarian Play Before Troriluzole's FDA Verdict (Seeking Alpha)
07:30AM	2 Wonderful Dividends At Bargain Basement Prices (Seeking Alpha)
May-04-25 11:20AM	Is Pfizer Inc. (PFE) The Most Profitable Cheap Stock to Buy Now? (Insider Monkey)
May-03-25 08:30AM	5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (May 2025) (Seeking Alpha)
04:51AM	The Play On Legend Biotech (Seeking Alpha)
01:26AM	Dividend Champion, Contender, And Challenger Highlights: Week Of May 4 (Seeking Alpha)
May-02-25 01:19PM	Trump Says Drug Tariffs Are Coming. Big Pharma Execs Cant Figure Out How Much to Worry. (Barrons.com)
10:00AM	Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon (Seeking Alpha)
09:01AM	Summit Therapeutics Q1 Loss Narrower Than Expected, Sales Nil (Zacks)
08:59AM	Zacks.com featured highlights Fox, Universal Technical Institute, Pfizer, Tenet Healthcare and Newmont (Zacks)
07:30AM	Build Your Own ATM: 2 Undervalued Dividend Machines Yielding 7% (Seeking Alpha)
03:51AM	3 No-Brainer Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought in May (Motley Fool)
03:03AM	Arvinas Inc (ARVN) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ... (GuruFocus.com)
May-01-25 09:05PM	The GLP-1 Saga Continues, And How (Seeking Alpha)
01:30PM	Moderna: Regulatory Hurdles And Market Challenges Prompt Downgrade To Sell (Seeking Alpha)
12:34PM	3 Market Predictions For May (Seeking Alpha)
12:06PM	'Declare victory and move on': Eli Lilly CEO on Trump tariff threat (Yahoo Finance)
11:51AM	LLY's Q1 Earnings Miss, Mounjaro & Zepbound Drive Sales, Stock Down (Zacks)
11:22AM	Moderna Beats on Q1 Earnings, Lags on Revenues, Focuses on Cost Cuts (Zacks)
08:57AM	Q1 2025 OPKO Health Inc Earnings Call (Thomson Reuters StreetEvents)
08:54AM	Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance (Yahoo Finance)
08:45AM	Dividend Harvesting Portfolio Week 217: $21,700 Allocated, $2,179.74 In Projected Dividends (Seeking Alpha)
08:40AM	Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks (Zacks)
07:15AM	3 High-Yield Dividend Stocks That Could Rally Near 52-Week Lows (MarketBeat)
04:50AM	Zacks.com featured highlights Centene, Pediatrix Medical, Pfizer, StoneCo and Banco Santander (Zacks)
04:15AM	Want Safe Dividend Income in 2025 and Beyond? Invest in the Following 3 Ultra-High-Yield Stocks. (Motley Fool)
03:17AM	OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... (GuruFocus.com)
Apr-30-25 04:27PM	BridgeBio Breaks Out After Pfizer-Rivaling Heart Drug Obliterates Sales Expectations (Investor's Business Daily)
09:10AM	Company News for Apr 30, 2025 (Zacks)
09:08AM	Boost Your Portfolio With These 5 Low Price-to-Book Stocks (Zacks)
07:05AM	Stock Market Crash: 3 Absurdly Cheap Stocks to Load Up on for the Long Haul (Motley Fool)
07:04AM	Market Rally at Risk as Tariffs Damage Spreads. And 5 Other Things to Know Today. (Barrons.com)
06:15AM	Pfizer's Dividend Yield Is 7.5%. Is It Still Safe? (Motley Fool)
04:51AM	Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback? (Motley Fool)
04:51AM	Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback? (Motley Fool)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13 '24	Sale	28.66	5,154	147,714	8,582	Aug 14 03:47 PM

TEM

Tempus AI Inc

PFE

Pfizer Inc

Upgrade your FINVIZ experience